Carlumab (Anti-CCL2 / MCP1)

Carlumab (Anti-CCL2 / MCP1) is a humanised monoclonal antibody targeting CCL2 with high affinity. Carlumab can be used in cancer research, particularly in prostate cancer. MW:145.5 KD.
Supplier Selleck Chemicals
Product # A2573
Sku # A2573-1mg
Pricing 1mg, $370.00
Feedback